SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-019220
Filing Date
2017-07-27
Accepted
2017-07-27 18:35:57
Documents
1
Period of Report
2017-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4083
  Complete submission text file 0000899243-17-019220.txt   5431
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AILERON THERAPEUTICS INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Yanchik Joseph A., III (Reporting) CIK: 0001618154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 17987411